The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer

Molecular Oncology

Volumn 9, Issue 6, 2015, Pages 1091-1105

  Li, Zhongwu ^a   Wang, Yanling ^a   Zhu, Yumin ^a   Yuan, Chunping ^a   Wang, Dongmiao ^a   Zhang, Wei ^a   Qi, Bin ^a   Qiu, Jin ^a   Song, Xiaomeng ^a   Ye, Jinhai ^a   Wu, Heming ^a   Jiang, Hongbing ^a   Liu, Laikui ^a   Zhang, Yuan ^b   Song, Liang Nian ^c   Yang, Jianrong ^a   Cheng, Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c Department of Medicine   (United States)

Author keywords

Cancer stem cell; Epithelial to mesenchymal transition; Hippo; Oral squamous cell carcinoma; TAZ

Indexed keywords

CISPLATIN; FLUOROURACIL; MESSENGER RNA; SIMVASTATIN; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL COACTIVATOR WITH PDZ BINDING MOTIF; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; HIPPO PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TAZ PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CERVICAL LYMPH NODE; COLONY FORMATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG POTENCY; DRUG POTENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTIONAL COACTIVATOR WITH PDZ BINDING MOTIF GENE; TUMOR SEEDING; TUMOR VOLUME; TUMOR XENOGRAFT; CELL DIFFERENTIATION; DRUG RESISTANCE; GENETICS; METABOLISM; METASTASIS; MOUTH TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84929514666     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.01.007     Document Type: Article

References (58)

1. Allegra E., Trapasso S., Pisani D., Puzzo L. The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: a review. Oncology 2014, 86:199-205.
2. Bartucci M., Dattilo R., Moriconi C., Pagliuca A., Mottolese M., Federici G., Benedetto A.D., Todaro M., Stassi G., Sperati F., Amabile M.I., Pilozzi E., Patrizii M., Biffoni M., Maugeri-Sacca M., Piccolo S., De Maria R. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene 2015, 34(6):681-690.
3. Beck B., Blanpain C. Unravelling cancer stem cell potential. Nat. Rev. Cancer 2013, 13:727-738.
4. Beck B., Lapouge G., Rorive S., Drogat B., Desaedelaere K., Delafaille S., Dubois C., Salmon I., Willekens K., Marine J.C., Blanpain C. Different levels of twist1 regulate skin tumor initiation, stemness, and progression. Cell Stem Cell 2015, 16:67-79.
5. Bhat K.P., Salazar K.L., Balasubramaniyan V., Wani K., Heathcock L., Hollingsworth F., James J.D., Gumin J., Diefes K.L., Kim S.H., Turski A., Azodi Y., Yang Y., Doucette T., Colman H., Sulman E.P., Lang F.F., Rao G., Copray S., Vaillant B.D., Aldape K.D. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011, 25:2594-2609.
6. Boumahdi S., Driessens G., Lapouge G., Rorive S., Nassar D., Le Mercier M., Delatte B., Caauwe A., Lenglez S., Nkusi E., Brohee S., Salmon I., Dubois C., del Marmol V., Fuks F., Beck B., Blanpain C. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 2014, 511:246-250.
7. Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A., Rodrigues L.O., Brooks M., Reinhardt F., Su Y., Polyak K., Arendt L.M., Kuperwasser C., Bierie B., Weinberg R.A. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. U S A 2011, 108:7950-7955.
8. Chaffer C.L., Marjanovic N.D., Lee T., Bell G., Kleer C.G., Reinhardt F., D'Alessio A.C., Young R.A., Weinberg R.A. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74.
9. Chan S.W., Lim C.J., Guo K., Ng C.P., Lee I., Hunziker W., Zeng Q., Hong W. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 2008, 68:2592-2598.
10. Chan S.W., Lim C.J., Loo L.S., Chong Y.F., Huang C., Hong W. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J.Biol. Chem. 2009, 284:14347-14358.
11. Cordenonsi M., Zanconato F., Azzolin L., Forcato M., Rosato A., Frasson C., Inui M., Montagner M., Parenti A.R., Poletti A., Daidone M.G., Dupont S., Basso G., Bicciato S., Piccolo S. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011, 147:759-772.
12. de Cristofaro T., Di Palma T., Ferraro A., Corrado A., Lucci V., Franco R., Fusco A., Zannini M. TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur. J. Cancer 2011, 47:926-933.
13. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
14. Fan R., Kim N.G., Gumbiner B.M. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc. Natl. Acad. Sci. U S A 2013, 110:2569-2574.
15. Grosse-Gehling P., Fargeas C.A., Dittfeld C., Garbe Y., Alison M.R., Corbeil D., Kunz-Schughart L.A. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J.Pathol. 2013, 229:355-378.
16. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nat. Med. 2009, 15:1010-1012.
17. Halder G., Dupont S., Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol 2012, 13:591-600.
18. Hao J., Zhang Y., Jing D., Li Y., Li J., Zhao Z. Role of Hippo signaling in cancer stem cells. J.Cell Physiol 2014, 229:266-270.
19. Harvey K.F., Zhang X., Thomas D.M. The Hippo pathway and human cancer. Nat. Rev. Cancer 2013, 13:246-257.
20. Hiemer S.E., Szymaniak A.D., Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J.Biol. Chem. 2014, 289:13461-13474.
21. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
22. Iliopoulos D., Hirsch H.A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. U S A 2011, 108:1397-1402.
23. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol 2014, 15:178-196.
24. Lei Q.Y., Zhang H., Zhao B., Zha Z.Y., Bai F., Pei X.H., Zhao S., Xiong Y., Guan K.L. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell Biol 2008, 28:2426-2436.
25. Li Z., Wang Y., Qiu J., Li Q., Yuan C., Zhang W., Wang D., Ye J., Jiang H., Yang J., Cheng J. The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer. Oncotarget 2013, 4:2532-2549.
26. Lian I., Kim J., Okazawa H., Zhao J., Zhao B., Yu J., Chinnaiyan A., Israel M.A., Goldstein L.S., Abujarour R., Ding S., Guan K.L. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 2010, 24:1106-1118.
27. Liu-Chittenden Y., Huang B., Shim J.S., Chen Q., Lee S.J., Anders R.A., Liu J.O., Pan D. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012, 26:1300-1305.
28. Liu L.K., Jiang X.Y., Zhou X.X., Wang D.M., Song X.L., Jiang H.B. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod. Pathol. 2010, 23:213-224.
29. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
30. Mauviel A., Nallet-Staub F., Varelas X. Integrating developmental signals: a Hippo in the (path)way. Oncogene 2012, 31:1743-1756.
31. Medema J.P. Cancer stem cells: the challenges ahead. Nat. Cell Biol 2013, 15:338-344.
32. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888.
33. Overholtzer M., Zhang J., Smolen G.A., Muir B., Li W., Sgroi D.C., Deng C.X., Brugge J.S., Haber D.A. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U S A 2006, 103:12405-12410.
34. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
35. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U S A 2007, 104:973-978.
36. Scheel C., Eaton E.N., Li S.H., Chaffer C.L., Reinhardt F., Kah K.J., Bell G., Guo W., Rubin J., Richardson A.L., Weinberg R.A. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011, 145:926-940.
37. Scheel C., Weinberg R.A. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?. Int. J. Cancer 2011, 129:2310-2314.
38. Schwitalla S., Fingerle A.A., Cammareri P., Nebelsiek T., Goktuna S.I., Ziegler P.K., Canli O., Heijmans J., Huels D.J., Moreaux G., Rupec R.A., Gerhard M., Schmid R., Barker N., Clevers H., Lang R., Neumann J., Kirchner T., Taketo M.M., van den Brink G.R., Sansom O.J., Arkan M.C., Greten F.R. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013, 152:25-38.
39. Scully C., Bagan J.V. Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes. Oral Oncol. 2009, 45:e25-30.
40. Sinha N., Mukhopadhyay S., Das D.N., Panda P.K., Bhutia S.K. Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol. 2013, 49:854-862.
41. Sorrentino G., Ruggeri N., Specchia V., Cordenonsi M., Mano M., Dupont S., Manfrin A., Ingallina E., Sommaggio R., Piazza S., Rosato A., Piccolo S., Del Sal G. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat. Cell Biol 2014, 16:357-366.
42. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
43. Tremblay A.M., Missiaglia E., Galli G.G., Hettmer S., Urcia R., Carrara M., Judson R.N., Thway K., Nadal G., Selfe J.L., Murray G., Calogero R.A., De Bari C., Zammit P.S., Delorenzi M., Wagers A.J., Shipley J., Wackerhage H., Camargo F.D. The Hippo transducer YAP1 Transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation. Cancer Cell 2014, 26(2):273-287.
44. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
45. Varelas X., Sakuma R., Samavarchi-Tehrani P., Peerani R., Rao B.M., Dembowy J., Yaffe M.B., Zandstra P.W., Wrana J.L. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol 2008, 10:837-848.
46. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol 2010, 12:468-476.
47. Wan L., Pantel K., Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med. 2013, 19:1450-1464.
48. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., Rich J.N. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 2008, 3:e3769.
49. Wang Z., Wu Y., Wang H., Zhang Y., Mei L., Fang X., Zhang X., Zhang F., Chen H., Liu Y., Jiang Y., Sun S., Zheng Y., Li N., Huang L. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc. Natl. Acad. Sci. U S A 2014, 111:E89-E98.
50. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344.
51. Yang C.C., Zhu L.F., Xu X.H., Ning T.Y., Ye J.H., Liu L.K. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 2013, 13:171.
52. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W.H., Huang C.H., Kao S.Y., Tzeng C.H., Tai S.K., Chang S.Y., Lee O.K., Wu K.J. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol 2010, 12:982-992.
53. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
54. Zhang H., Liu C.Y., Zha Z.Y., Zhao B., Yao J., Zhao S., Xiong Y., Lei Q.Y., Guan K.L. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J.Biol. Chem. 2009, 284:13355-13362.
55. Zhao B., Tumaneng K., Guan K.L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol 2011, 13:877-883.
56. Zhou J., Ng S.B., Chng W.J. LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. Int. J. Biochem. Cell Biol 2013, 45:973-978.
57. Zhu L.F., Hu Y., Yang C.C., Xu X.H., Ning T.Y., Wang Z.L., Ye J.H., Liu L.K. Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. Lab Invest 2012, 92:744-752.
58. Zomer A., Ellenbroek S.I., Ritsma L., Beerling E., Vrisekoop N., Van Rheenen J. Intravital imaging of cancer stem cell plasticity in mammary tumors. Stem Cells 2013, 31:602-606.